ARNI (Heart Failure)Conditionally Approved

Sacubitril-Valsartan

Brand names: Entresto|Last verified: 2026-03-01

FAA Pathway: Special Issuance required — heart failure evaluation mandatory

Sacubitril-valsartan requires Special Issuance evaluation. As a heart failure medication, the underlying cardiac condition must be thoroughly documented including ejection fraction, functional status, and exercise tolerance.

Check your medications

Look up any medication in our FAA compatibility database.

Medication Checker

Pilot Tip

Always report all medications on your FAA medical application (Form 8500-8, Item 17a), even OTC medications. Failure to disclose is a far bigger issue than the medication itself.

Certification Details

Key Requirements
Comprehensive cardiac evaluation, ejection fraction documentation
Certificate Classes
Depends on heart failure severity
Monitoring
Regular cardiac follow-up, BNP levels
Notes
Heart failure certification is possible but requires extensive documentation

Sources

  • FAA AME Guide, Cardiology

Last verified: 2026-03-01

Frequently Asked Questions

Is Sacubitril-Valsartan allowed for pilots?

The FAA considers Sacubitril-Valsartan (Entresto) to be "Conditionally Approved" for medical certification purposes. Sacubitril-valsartan requires Special Issuance evaluation. As a heart failure medication, the underlying cardiac condition must be thoroughly documented including ejection fraction, functional status, and exercise tolerance.

What is the FAA status of Sacubitril-Valsartan?

Sacubitril-Valsartan has a status of "Conditionally Approved" under FAA medical certification policy. The certification pathway is: Special Issuance required — heart failure evaluation mandatory.

Can I fly while taking Sacubitril-Valsartan?

Flying while taking Sacubitril-Valsartan may be possible through the FAA's Special Issuance process. You will need to meet specific requirements and obtain approval before exercising pilot privileges. Consult an experienced AME for guidance.

Important Notice

The FAA does not publish a comprehensive list of “approved” medications. The information on this page represents our interpretation of publicly available FAA guidance and is provided for informational and educational purposes only. It does not constitute medical advice, legal advice, or a guarantee of certification outcome.

The primary issue with the FAA is always whether the underlying medical condition — not just the medication — is compatible with safe flight. You should only start, stop, or change medications after consulting your treating physician. Always consult with a qualified Aviation Medical Examiner (AME) for guidance specific to your situation. FAA policies are subject to change. ClearedMed is not affiliated with or endorsed by the FAA.